Abstract
T-cell immunocompetence and diversity are thought to be generated in the thymus1,2. This view is based on the findings that (1) T-cell ontogeny is thymus dependent3,4, (2) the major histocompatibility restrictions of T-cell interactions are phenotypically related to the H–2 type of the thymus5–9, and (3) the phenotypic manifestation of H–2-linked immune responsiveness parallels the restriction elements selected in thymus10–12. However, it is unclear whether pre-thymic cells programmed to develop into T cells do already express a receptor diversity, also whether pre-thymic cells have the potential to react against self-antigens, and whether the mechanism of self-tolerance is initiated in the thymus by either elimination or suppression of self-reactive clones. If it were possible to confer on pre-thymic cells antigen-specific effector functions, the impact of the thymus on the generation of T-cell diversity and function could be analysed in more detail. In mice, the nude mutation lacks a functioning thymus13,14; nu/nu mice possess a thymic rudiment which is epithelial in the embryo15 and a fibrous, cystic remnant in adult15,16; this remnant is not populated by lymphoid cells15–17. At present, the absence of immunocompetent T cells in nu/nu mice is explained by a lack of thymic differentiation and maturation of pre-thymic cells (reviewed in ref. 13). Here we report that injection of allogeneic stimulator cells plus a Lyt 1 T-cell-derived helper factor18,19, termed interleukin 2 (for the system of nomenclature, see ref. 20) allows lymphocytes of nu/nu mice to differentiate in vivo into alloreactive cytotoxic T lymphocytes (CTLs).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burnet, F. M. Immunological Surveillance (Pergamon, Sydney, 1970).
Jerne, N. K. Eur. J. Immun. 1, 1–9 (1971).
Miller, J. F. A. P. & Osoba, D. Physiol. Rev. 47, 437–478 (1967).
Davies, A. J. S., Lenchars, E., Wallis, V., Marchant, R. & Elliot, E. V. Transplantation 5, 222–231 (1967).
Doherty, P. C., Blanden, R. V. & Zinkernagel, R. M. Transplant. Rev. 29, 89–124 (1976).
Zinkernagel, R. M. et al. J. exp. Med. 147, 822–896 (1978).
Bevan, M. J. Nature 269, 417–418 (1978).
Pfizenmaier, K., Starzinski-Powitz, A., Rodt, H., Röllinghoff, M. & Wagner, H. J. exp. Med. 143, 999–1004 (1976).
Gordon, R. D., Simpson, E. & Samelson, L. E. J. exp. Med. 142, 1108–1120 (1975).
v. Boehmer, H., Haas, W. & Jerne, N. K. Proc. natn. Acad. Sci. U.S.A. 75, 2439–2441 (1978).
Matsunaga, T. & Simpson, E. Proc. natn. Acad. Sci. U.S.A. 75, 6207–6209 (1978).
Zinkernagel, R. M., Althage, A., Cooper, S., Callahan, G. N. & Klein, J. J. exp. Med. 148, 805–810 (1978).
Kindred, B. Prog. Allergy 26, 137–238 (1979).
Pantelouris, E. M. Nature 217, 370–371 (1968).
Jordan, R. K., Owen, J. J. T. & Raff, M. C. Eur. J. Immun. 7, 736–743 (1977).
Owen, J. J. T., Jordan, R. F. & Raff, M. C. Eur. J. Immun. 5, 653–656 (1975).
Cordier, A. C. J. ultrastruct. Res. 47, 26–32 (1974).
Wagner, H. & Röllinghoff, M. J. exp. Med. 148, 1523–1528 (1977).
Watson, J., Gillis, St., Marbrook, J., Mochizuki, D. & Smith, K. A. J. exp. Med. 150, 849–861 (1979).
2nd Int. Workshop, Ermatingen (1979).
Wagner, H., Röllinghoff, M., Schawaller, R., Hardt, C. & Pfizenmaier, K. Nature 280, 5721–5722 (1979).
Irlé, C., Piguet, P. F. & Vasalli, P. J. exp. Med. 148, 32–45 (1978).
Wagner, H., Röllinghoff, M., Pfizenmaier, K., Hardt, C. & Johnscher, G. J. Immun. (in the press).
Piguet, P. F. & Vasalli, P. J. Immun. 120, 79–83 (1978).
Loor, F., Amstutz, H., Hägg, L. B., Major, K. S. & Rochants, G. E. Eur. J. Immun. 6, 663–667 (1976).
Hair, J. in Proc. 1st Int. Workshop in Nude Mice, 23 (Fischer, Stuttgart, 1974).
Feldman, M., Wagner, H., Basten, A. & Holmes, M. Aust. J. exp. Biol. med. Sci. 50, 651–660 (1972).
Wagner, H. J. Immun. 109, 630–635 (1972).
Komuro, K. & Boyse, E. A. J. exp. Med. 138, 479–483 (1973).
Scheid, M. P., Golstein, G. & Boyse, E. A. Science 190, 2111–2112 (1974).
Sato, V. L., Waksal, S. D. & Herzenberg, L. A. Cell. Immun. 24, 173–179 (1976).
Milewicz, C., Miller, H. G. & Esselman, W. J. J. Immun. 117, 1774–1779 (1976).
Scheid, M. P. et al. J. exp. Med. 138, 1027–1031 (1973).
Gillis, St., Union, N. A., Baker, P. E. & Smith, K. A. J. exp. Med. 149, 1460–1476 (1979).
Bevan, M. J. Proc. natn. Acad. Sci. U.S.A. 74, 2094–2098 (1977).
Finberg, R., Burakoff, St., Cantor, H. & Benacerraf, B. Proc. natn. Acad. Sci. U.S.A. 75, 5145–5149 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wagner, H., Hardt, C., Heeg, K. et al. T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice. Nature 284, 278–280 (1980). https://doi.org/10.1038/284278a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/284278a0
This article is cited by
-
Reduced Oxidative Stress Promotes NF-κB-Mediated Neuroprotective Gene Expression after Transient Focal Cerebral Ischemia: Lymphocytotrophic Cytokines and Antiapoptotic Factors
Journal of Cerebral Blood Flow & Metabolism (2007)
-
In vivo system to detect long-term continuous release of bioactive interleukin-2 by immunopharmacological depot preparations in nude mice with human tumors
Journal of Cancer Research and Clinical Oncology (1995)
-
Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review
Cancer Immunology, Immunotherapy (1993)
-
Intratumoral interleukin-2 immunotherapy: Activation of tumor-infiltrating and splenic lymphocytes in vivo
Cancer Immunology Immunotherapy (1993)
-
Regulation of interleukin-2 and interferon-γ gene expression in renal failure
Kidney International (1991)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.